HOSPITAL UNIVERSITARIO RUBER
Departamento
Hospital Italiano de Buenos Aires
Buenos Aires, ArgentinaPublicaciones en colaboración con investigadores/as de Hospital Italiano de Buenos Aires (7)
2023
-
Clinical characterization and treatment outcomes of follicular cutaneous immune–related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study
Journal of the American Academy of Dermatology, Vol. 88, Núm. 3, pp. 718-720
-
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
Cancers, Vol. 15, Núm. 14
2022
-
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients*
British Journal of Dermatology, Vol. 187, Núm. 6, pp. 962-969
-
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement
Journal of the European Academy of Dermatology and Venereology, Vol. 36, Núm. 3, pp. 332-350
2021
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2011
-
Segundo Consenso Clínico de la Sociedad Iberoamericana de Neonatología: Manejo hemodinámico del recién nacido
Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 29, Núm. 4, pp. 281-302
2008
-
Primer consenso clínico de SIBEN: Enfoque diagnóstico y terapéutico del ductus arterioso permeable en recién nacidos pretérmino
Anales de Pediatria, Vol. 69, Núm. 5, pp. 454-481